Eagle Pharmaceuticals Aktie Analyse
01.11.18 | Eagle Pharmaceuticals Neutral | Cantor Fitzgerald | |
21.03.18 | Eagle Pharmaceuticals Underperform | Mizuho | |
09.11.17 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
06.09.17 | Eagle Pharmaceuticals Underperform | Mizuho | |
27.07.17 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
27.07.17 | Eagle Pharmaceuticals Underperform | Mizuho | |
09.05.17 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
09.01.17 | Eagle Pharmaceuticals Underperform | Mizuho | |
Werbung
|
|||
16.11.16 | Eagle Pharmaceuticals Neutral | Mizuho | |
03.11.16 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
03.11.16 | Eagle Pharmaceuticals Buy | Mizuho | |
26.10.16 | Eagle Pharmaceuticals Buy | Mizuho | |
20.06.16 | Eagle Pharmaceuticals Neutral | Mizuho | |
10.05.16 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
18.03.16 | Eagle Pharmaceuticals Buy | Mizuho | |
26.02.16 | Eagle Pharmaceuticals Buy | Mizuho | |
09.12.15 | Eagle Pharmaceuticals Buy | Mizuho |